Cite
Fouda AY, Eldahshan W, Xu Z, et al. Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury. Exp Neurol. 2021;348:113923doi: 10.1016/j.expneurol.2021.113923.
Fouda, A. Y., Eldahshan, W., Xu, Z., Lemtalsi, T., Shosha, E., Zaidi, S. A., Abdelrahman, A. A., Cheng, P. N., Narayanan, S. P., Caldwell, R. W., & Caldwell, R. B. (2022). Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury. Experimental neurology, 348113923. https://doi.org/10.1016/j.expneurol.2021.113923
Fouda, Abdelrahman Y, et al. "Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury." Experimental neurology vol. 348 (2022): 113923. doi: https://doi.org/10.1016/j.expneurol.2021.113923
Fouda AY, Eldahshan W, Xu Z, Lemtalsi T, Shosha E, Zaidi SA, Abdelrahman AA, Cheng PN, Narayanan SP, Caldwell RW, Caldwell RB. Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury. Exp Neurol. 2022 Feb;348:113923. doi: 10.1016/j.expneurol.2021.113923. Epub 2021 Nov 12. PMID: 34780773.
Copy
Download .nbib